Skip to main content
Intermediate Technical IVT

NAFLD

Also written as: NAFLD — Non-alcoholic fatty liver disease

A liver condition characterized by fat accumulation in hepatocytes without significant alcohol consumption, commonly associated with insulin resistance and metabolic dysfunction.

Full Definition

Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of liver conditions ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. It is the most common chronic liver disease globally and is strongly associated with obesity, type 2 diabetes, and cardiovascular disease. The condition is diagnosed when hepatic fat content exceeds 5% of liver weight in the absence of significant alcohol consumption or other causes of hepatic steatosis. NAFLD has become increasingly important in cardiometabolic medicine as it represents a hepatic manifestation of insulin resistance and is considered an independent risk factor for cardiovascular events.

Usage

Usage note: Distinguish clearly from NASH, which represents the inflammatory subtype of NAFLD.

In Context

  • "The prevalence of NAFLD has increased dramatically alongside the obesity epidemic." — Epidemiological study
  • "Patients with type 2 diabetes should be screened for NAFLD using liver enzymes and imaging studies." — Clinical practice guideline

Also known as

non-alcoholic fatty liver disease hepatic steatosis

Contrasted with

alcoholic fatty liver disease

Don't confuse with

NASH

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON